4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-006674
CHIEF MEDICAL OFFICER sold 18,844 shares at $21.77 ($410,234)
- CHIEF MEDICAL OFFICER acquired 18,844 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Paolini John F. CHIEF MEDICAL OFFICER | 2024-03-01 | Option exercise 10b5-1 | +18,844 | $1.86 | $35,050 | 62,736 | D |
| Paolini John F. CHIEF MEDICAL OFFICER | 2024-03-01 | Sale 10b5-1 | −18,844 | $21.77 | $410,234 | 44,892 | D |
| Derivatives | |||||||
| Paolini John F. CHIEF MEDICAL OFFICER | 2024-03-01 | Option exercise · Share Option 10b5-1 | −18,844 | 82,217 | D | ||
| Open-market sales · 18,844 sh · avg $21.77 · $410,234 | |||||||
Loading xslF345X05/form4-03052024_090325.xml…